Antibiotic consumption in southern and eastern Mediterranean hospitals: Results from the ARMed project

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 4, 2008, Pages 830-836

  Borg, Michael A ^a   Zarb, Peter ^a   Ferech, Matus ^b   Goossens, Herman ^b   Gur D ^c   Ben Redjeb, S ^c   Rasslan, O ^c   Elnassar, Z ^c   Bagatzouni, D P ^c   Daoud, Z ^c  

^a MATER DEI HOSPITAL   (Malta)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c NONE

Author keywords

ATC; Carbapenems; Cephalosporins; DDD; Penicillins; Resistance; Surveillance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CHLORAMPHENICOL DERIVATIVE; FLUCLOXACILLIN; FUSIDIC ACID; LINCOSAMIDE DERIVATIVE; MACROLIDE; MONOBACTAM DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CYPRUS; DRUG UTILIZATION; EGYPT; GENERAL HOSPITAL; HOSPITAL CARE; INFECTION CONTROL; JORDAN; LEBANON; MALTA; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; SOUTHERN EUROPE; TEACHING HOSPITAL; TUNISIA; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

EID: 52949133072     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn260     Document Type: Article

References (25)

1. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5: 1033-48.
2. Lopez-Lozano JM, Monnet DL, Yague A et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to anti-microbial use: A time series analysis. Int J Antimicrob Agents 2000; 14: 21-31.
3. Shlaes DM, Gerding DN, John JF Jr et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584-99.
4. Olson B, Weinstein RA, Nathan C et al. Epidemiology of endemic Pseudomonas aeruginosa: Why infection control efforts have failed. J Infect Dis 1987; 150: 808-16.
5. Levy SB. Balancing the drug-resistance equation. Trends Microbiol 1994; 2: 341-2.
6. Council Recommendation on the Prudent Use of Antimicrobial Agents in Human Medicine (2002/77/EC). Brussels: European Commission, 2001.
7. Gur D, Unall S. Resistance to antimicrobial agents in Mediterranean countries. Int J Antimiciob Agents 2001; 17: 21-6.
8. Tiemersma EW, Bronzwaer SL, Lyytikainen O et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-34.
9. Borg MA, de Kraker M, Scicluna E et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. J Antimicrob Chemother 2007; 60: 1310-5.
10. MacKenzie FM, Struelens MJ, Towner KJ et al. Report of the Consensus Conference on Antibiotic Resistance, Prevention and Control (ARPAC). Clin Microbiol Infect 2005; 11: 938-54.
11. Vander Stichele RH, Elseviers MM, Ferech M et al. European surveillance of antimicrobial consumption (ESAC): Data collection performance and methodological approach. Br J Clin Pharmacol 2004; 58: 419-28.
12. Borg MA, Scicluna E. Antibiotic resistance in the Mediterranean region: the ARMed project. Euro Surveill (serial online) 2004; 8: http://www.eurosurveillance.org/ew/2004/040212.asp#5 (date last accessed, 12 December 2007).
13. Westh H, Zinn CS, Rosdahl VT. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist 2004; 10: 169-76.
14. MacKenzie FM, Monnet DL, Gould IM; ARPAC Steering Group. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006; 58: 657-60.
15. Raveh D, Levy Y, Schlesinger Y et al. Longitudinal surveillance of antibiotic use in the hospital. QJM 2001; 94: 141-52.
16. Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10: 1432-41.
17. Borg MA, Scicluna E, do Kraker M et al. Antibiotic resistance in the southeastern Mediterranean-preliminary results from the ARMed project. Euro Surveill 2006; 11: 164-7.
18. Lieberman JM. Appropriate antibiotic use and why it is important: The challenges of bacterial resistance. Pediatr Infect Dis J 2003; 22: 1143-51.
19. Crowcroft NS, Ronveaux O, Monnot DL et al. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999; 20: 31-6.
20. Rahal JJ, Urban C, Hom D. Class restriction of cephallosporin use to control total cephalosporin resistance in nosocomial Klebsiella. J Am Med Assoc 1998; 280: 1270-1.
21. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneuminiae: A case-control study in a district hospital in Taiwan. J Hosp Infect 2003; 53: 39-45.
22. Borg MA, Cookson BD, Scicluna E et al. Survey of infection control infrastructure in selected southern and eastern Mediterranean hospitals. Clin Microbiol Infect 2007; 13: 344-6.
23. Warren DK, Fraser VJ. Infection control measures to limit anti-microbial resistance. Crit Care Med 2001; 29: N128-34.
24. Monnet DL. Toward multinational antimicrobial resistance surveillance systems in Europe. Int J Antimicrob Agents 2000; 15: 91-101.
25. Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis 2006; 42: S90-5.